Efficacy and Safety of IV Diclofenac (DIC075V) for Pain After Abdominal or Pelvic Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

331

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Pain, Postoperative
Interventions
DRUG

Intravenous Diclofenac (DIC075V)

Intravenous Diclofenac (DIC075V): 1 of 2 dosage levels

DRUG

Intravenous Ketorolac

Intravenous Ketorolac

DRUG

placebo

placebo

Trial Locations (14)

27710

Duke University Medical Center, Durham

33437

Visions Clinical Research, Boynton Beach

35235

Alabama Clinical Therapeutics, Birmingham

35630

Eliza Coffee Memorial Hospital, Florence

35660

Helen Keller Hospital, Sheffield

36106

Drug Research and Analysis Corp., Montgomery

58501

Clinical Research Services, Bismarck

72205

Teton Research / Parkview Surgical, Little Rock

77024

Memorial Hermann Healthcare System - Memorial City Hospital, Houston

78666

Clinical Research Center, San Marcos

78705

Clinical Research Center, Austin

84124

Jean Brown Research, Salt Lake City

91206

Glendale Adventist Medical Center, Glendale

92653

Saddleback Memorial Medical Center, Laguna Hills

Sponsors
All Listed Sponsors
lead

Javelin Pharmaceuticals

INDUSTRY